Table 2.

Bone marrow counts of leukemic FLT3W51/PML-RARα mice

MiceImm/BlIntermediateNeutrophilsErythrocytesLymphocytesEosinophilsOther
Control 2.8 15.7 25.6 39.9 13.7 2.6 
PML-RARα leukemia 81.3 4.5 0.7 8.7 4.6 0.3 
PML-RARα/FLT3W51leukemia 68.5 7.0 4.2 12.8 3.8 0.9 2.5 
874 85.8 1.5 2.5 2.8 4.3 
1019 64.5 13 11.5 4.8 3.5 
1020 75.8 7.5 1.5 4.3 8.8 2.3 
1086 50.8 2.3 0.5 36 4.5 0.8 2.3 
1087 66.3 8.3 4.5 15.8 2.5 0.25 0.5 
1127 65.5 10.3 9.3 10.5 3.3 0.3 0.5 
1128 70.8 3.3 0.8 18 2.8 0.3 
MiceImm/BlIntermediateNeutrophilsErythrocytesLymphocytesEosinophilsOther
Control 2.8 15.7 25.6 39.9 13.7 2.6 
PML-RARα leukemia 81.3 4.5 0.7 8.7 4.6 0.3 
PML-RARα/FLT3W51leukemia 68.5 7.0 4.2 12.8 3.8 0.9 2.5 
874 85.8 1.5 2.5 2.8 4.3 
1019 64.5 13 11.5 4.8 3.5 
1020 75.8 7.5 1.5 4.3 8.8 2.3 
1086 50.8 2.3 0.5 36 4.5 0.8 2.3 
1087 66.3 8.3 4.5 15.8 2.5 0.25 0.5 
1127 65.5 10.3 9.3 10.5 3.3 0.3 0.5 
1128 70.8 3.3 0.8 18 2.8 0.3 

Bone marrow nucleated cell differential counts (%) of control, leukemic PML-RARα, and leukemic FLT3W51/PML-RARα mice are shown as mean values along with data from seven individual FLT3W51/PML-RARα mice. Erythrocytes: nucleated erythroid cells. Other: includes monocytes, macrophages, plasma cells, mast cells. Control n = 7, PML-RARα leukemias n = 6, FLT3W51/PML-RARα leukemias n = 7. Compared with control, FLT3W51/PML-RARα leukemias show a statistically significant difference for all cell types. The bone marrows of PML-RARα leukemias have significantly more immature forms/blasts than the bone marrows of FLT3W51/PML-RARα leukemias (P = .03). Some of the control and PML-RARα leukemia data have been previously reported.28 46 

Close Modal

or Create an Account

Close Modal
Close Modal